BiliaryTractCancer near San Marcos, TX

Biography: Dr. Kyriakos P. Papadopoulos is the Co-Director of Clinical Research at START in San Antonio. He is board-certified in Internal Medicine, Medical Oncology & Hematology. His clinical interests include drug development and malignancies of the upper gastrointestinal-tract and lungs.Dr. Papadopoulos completed his MBBCh and MSc (Med) at the University of Witwatersrand, Johannesburg, and his specialty training in Internal Medicine at Groote Schuur Hospital, Cape Town, South Africa. He followed this with a fellowship in Medical Oncology and Hematology at the College of Physicians and Surgeons of Columbia University, NY.Prior to his arrival in San Antonio, Dr. Papadopoulos was the Florence Irving Assistant Professor of Medicine at the College of Physicians and Surgeons of Columbia University, where he was co-director of the GI and Lung Tumor Clinic. He received a Career Development Award from the National Institute of Health, as well as immunotherapy research funding from the Cancer Research Institute.Dr. Papadopoulos was appointed Clinical Associate Professor of Medicine at the University of Texas Health Science Center at San Antonio. He was also senior clinical investigator at the Cancer Therapy & Research Center's (CTRC) Institute for Drug Development, San Antonio, TX and a member of the CTRC's Medical Executive Committee.He is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, Southwest Oncology Group, and a Fellow of the College of Physicians of South Africa.Dr. Papadopoulos serves as a reviewer for a number of oncology journals and has authored numerous peer reviewed articles, chapters and abstracts at international meetings.

Care Philosophy: To provide excellent, evidence-based care for each patient we serve, while advancing cancer care for tomorrow.

Biography: Dr. Tony Harb earned his medical degree at the Saint Joseph University in Lebanon. He then went on to complete his Internal medicine residency and a chief residency year at the University at Buffalo in New York, and a Hematology-Oncology fellowship at the University of Medicine and Dentistry of New Jersey (UMDNJ). He started his career at the Northern Light Cancer Care Center in Maine, where he was instrumental in expanding a comprehensive lung cancer program. He practiced there for more than 7 years with a focus on thoracic oncology and head and neck malignancies, and research interests in quality care and outcome metrics. He obtained a Master's in business administration from the University of the Incarnate Word in San Antonio.Dr. Harb is board certified in Internal Medicine, Hematology and Medical Oncology. He is fluent in French and Arabic.During his free time, he enjoys hiking and swimming with his wife and their two children. He practices primarily at the Medical Drive location.

Biography: Dr. Salih received his undergraduate degree in 2003 from Baylor University, majoring in Bioinformatics. He earned a PhD in Genetics from Texas A&M University in 2008, with a research focus in genomics and computational biology. He is both a contributing author and primary author of numerous publications in genomics-based sciences. Dr. Salih was awarded the Spirit of the Program Award as a resident in Internal Medicine at the University of Mississippi Medical center. After completing training in Internal Medicine, he completed fellowship training in Hematology/Oncology at the University of Texas Health Science Center at San Antonio in 2018. Dr. Salih treats both benign and malignant hematology along with all solid tumor cancer types, with a particular interest in genitourinary, lung and gastrointestinal malignancies.

Care Philosophy: TO provide excellent, evidence-based care for each patient we serve, while advancing cancer care for tomorrow.